Literature DB >> 6697591

Parathyroid hormone, calcitonin, and vitamin D metabolites during normal fracture healing in humans. A preliminary report.

Y Meller, R Shainkin-Kestenbaum, S Shany, I Zuilli, N Yankowitz, J Giat, A Konforti, G Torok.   

Abstract

The metabolism of calcium is regulated by hormones: parathyroid hormone, (PTH) calcitonin (CT), and vitamin D metabolites. To study the physiologic role of these hormones during the process of fracture healing in humans, the blood levels of PTH, CT, 25-(OH)-D3, 24,25-(OH)2-D3, and calcium were determined in 13 young patients with fractures of long bones. The parameters were measured first on admission and again after six to eight weeks. A group of healthy volunteers of similar age and sex served as control subjects. Plasma calcium level on the day of fracture was significantly reduced, 8.50 +/- 0.23 mg% (p less than 0.001). Serum CT level on the day of fracture was significantly increased, 0.18 +/- 0.02 ng/ml (p less than 0.05), and it continued to increase during the healing period, up to 0.23 +/- 0.02 ng/ml (p less than 0.001) after six to eight weeks. A significant rise was noted in plasma level of 24,25-(OH)2-D3, from 2.02 +/- 0.42 ng/ml on the day of fracture to 2.84 +/- 0.41 ng/ml six weeks later (p less than 0.05). No significant changes were found in serum PTH and plasma 25-(OH)-D3 levels on the day of fracture or during the healing process. The results suggest a possible physiologic active role for CT and 24,25-(OH)2-D3 in fracture healing in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697591

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Distraction osteogenesis enhances remodeling of remote bones of the skeleton: a pilot study.

Authors:  Julia F Funk; Gert Krummrey; Carsten Perka; Michael J Raschke; Hermann J Bail
Journal:  Clin Orthop Relat Res       Date:  2009-05-29       Impact factor: 4.176

2.  Optimal bone fracture repair requires 24R,25-dihydroxyvitamin D3 and its effector molecule FAM57B2.

Authors:  Corine Martineau; Roy Pascal Naja; Abdallah Husseini; Bachar Hamade; Martin Kaufmann; Omar Akhouayri; Alice Arabian; Glenville Jones; René St-Arnaud
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

3.  Time course of 25(OH)D3 vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD).

Authors:  Christoph Wölfl; Christoph Wöfl; Sarah Englert; Arash A Moghaddam; Gerald Zimmermann; Heinrich Schmidt-Gayk; Gerhard Schmidt-Gayk; Bernd Höner; Aidan Hogan; Marcus Lehnhardt; Paul A Grützner; Leila Kolios
Journal:  BMC Musculoskelet Disord       Date:  2013-01-03       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.